Atlas Trials

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

Clinical trial NCT00171977 · COMPLETED

Trial details

NCT number
NCT00171977
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumors
Start date
2004-07-01
Primary completion
2009-04-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.